ストックスクリーナーアプリを入手
36.05
1.47%
0.5209
前日終値:
$35.53
開ける：
$35.7
24時間の取引高:
42,521
Relative Volume:
3.54
時価総額：
$N/A
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+6.25%
1か月 パフォーマンス:
+20.00%
6か月 パフォーマンス:
+48.60%
1年 パフォーマンス:
+31.93%
1日の値動き範囲:
$35.55
$36.05
1週間の範囲:
$33.80
$36.05
52週間の値動き範囲:
$20.10
$36.05
Tema Oncology Etf Stock (CANC) Company Profile
CANC を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CANC
Tema Oncology Etf
|
36.05 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.29 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
681.32 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
684.71 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
258.52 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
615.43 | 124.43B | 0 | 0 | 0 | 0.00 |
Tema Oncology Etf (CANC) 最新ニュース
The AI Pharma Rally Is Real — And Cancer May Soon Be Chronic, Not Deadly - Benzinga
Be Thankful to These ETFs This Year - Yahoo Finance
Behavioral Patterns of CANC and Institutional Flows - news.stocktradersdaily.com
Inside the Recent Strength in Biotech ETFs - TradingView
(CANC) Movement Within Algorithmic Entry Frameworks - news.stocktradersdaily.com
How (CANC) Movements Inform Risk Allocation Models - news.stocktradersdaily.com
Biotech ETFs Bounce Back in 2025: Here's Why - sharewise.com
Aug PostEarnings: Is Tema ETF Trust Tema International stock among top earnings playsInsider Selling & Reliable Volume Spike Trade Alerts - nchmf.gov.vn
5 Small-cap Biotech ETFs to Watch in 2025 - Investing News Network
ETFs with Bristol-Myers Squibb Company ( BMY ) Exposure - ETF Database
What hedge fund moves indicate for Tema ETF Trust Tema Monopolies stockLayoff News & Growth Focused Stock Reports - newser.com
Short Interest in Tema Oncology ETF (NASDAQ:CANC) Increases By 264.8% - Defense World
Tema Etfs LLC Grows Stock Holdings in CG Oncology, Inc. $CGON - MarketBeat
How to Take Advantage of moves in (CANC) - news.stocktradersdaily.com
Analysts Predict Tema Oncology ETF to Reach $40, with Stocks CELC, ACLX, and ZYME Showing Significant Upside Potential - AInvest
Summit Therapeutics Explodes 12%: Legal Probe Ignites Volatility Amid Regulatory Crosshairs - AInvest
Summit Therapeutics Soars 16.5% Amid Regulatory Crossroads and Whale Activity - AInvest
When (CANC) Moves Investors should Listen - news.stocktradersdaily.com
5 Small-cap Biotech ETFs to Watch - Nasdaq
(CANC) Investment Report - news.stocktradersdaily.com
(CANC) Technical Data - news.stocktradersdaily.com
Bristol-Myers Squibb At ASCO 2025: A Resilient Play Amid Market Turbulence (NYSE:BMY) - Seeking Alpha
ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177 - Investing News Network
Biotech Outperformance: Can’t Take What’s Already Earned - Seeking Alpha
AAPG Stock Price and Chart — NASDAQ:AAPG - TradingView
7 Best-Performing Biotech ETFs for March 2025 - NerdWallet
Disruptive Theme of the Week: Breakthroughs in Medicine - ETF Trends
Tema ETF Trust Tema Oncology ETF (NASDAQ: CANC)Related Research - intelligentinvestor.com.au
5 Small-cap Biotech ETFs to Watch (Updated 2024) - Nasdaq
Tema American Reshoring ETF: Benefiting From The Return Of U.S. Manufacturing - Seeking Alpha
Tema Neuroscience And Mental Health ETF (MNTL) stock price, news, quote and history - Yahoo Finance UK
Tema Oncology ETF (CANC) Holdings - Yahoo! Finance Canada
Tema Oncology ETF (CANC) stock price, news, quote and history - Yahoo Finance UK
Tema Oncology ETF (CANC) Stock Trends and Sentiment 2025 - MarketBeat
Tema ETFs CIO on Investment Opportunities in Biotech - CMC Markets
Pursuing A Better Way To Invest In Life Sciences | Opto Partners - CMC Markets
How Big Pharma Is Taking A Page Out Of Novartis' Playbook - Investor's Business Daily
10 Best Performing Biotech ETFs in 2024 - Yahoo Finance
9 Best Biotech ETFs for 2024 - AOL.com
The 5 Best Biotech ETFs of 2024 - ETF.com
11 Best Biotech ETFs To Buy - Yahoo Finance
Tema Oncology ETF (CANC) Stock Price, News, Quote & History - Yahoo! Finance Canada
CANC ETF Analysis: Dividends, Returns NASDAQ:CANC - TradingView
Roundhill Daily 2X Long Magnificent Seven ETF Holdings List (NASDAQ:MAGX) - MarketBeat
ERShares Entrepreneurs ETF (ENTR) Short Interest Ratio and Volume 2025 - MarketBeat
Tema Launches Third Medical-Themed ETF - FA Mag
Tema Oncology ETF (CANC) Dividend Yield 2025, Date & History - MarketBeat
New ETF Focuses On Obesity, Cardiovascular Disease Treatments - FA Mag
Tema launches cardio-focused biotech ETF - ETF Strategy
Tema ETFs hops on weight-loss drug frenzy with its new cardiovascular fund - Reuters
CANCTema Oncology ETF Stock Price and Quote - Finviz
Tema Oncology Etf (CANC) 財務データ
Tema Oncology Etf (CANC) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
0.91%
大文字化:
|
ボリューム (24 時間):